Ads
related to: Prostate Cancer Treatment- nmCRPC Treatment Option
31% Risk of Death Decrease
Visit The Patient Site.
- Dosing & Administration
View Recommended Dosage & Learn
About Drug Interactions Here.
- Clinical Information
Read About A Double-Blind, Placebo-
Controlled, Randomized Study.
- mHSPC Treatment Option
32% Risk of Death Decrease
Visit The Patient Site.
- Downloadable Resources
Resources For Physicians & Patients
Available On The Site To Download.
- Patient Profiles
Explore Patient Profiles To Assess
A Treatment Option.
- nmCRPC Treatment Option
Search results
As they enter their 60s, Gen Xers projected to see cancer higher rates than Boomers
WLRN Miami· 3 days agoAs they head into their golden years, Gen-Xers are more likely to be diagnosed with cancer than the...
Kate Middleton Celebrates Prince William's Birthday With Family Photo
E! News via Yahoo News· 2 days agoIn honor or Prince William's 42nd birthday, Kate Middleton shared a sweet photo of the Prince of...
Prince William Takes Kids to Taylor Swift's Eras Tour Concert for His Birthday - E! Online
E! Online· 2 days agoPrince William celebrated his 42nd birthday at Taylor Swift's Eras Tour performance at Wembley...
Multiple New Awards Recognize NCCN as Exceptional | Newswise
Newswise· 6 days agoPLYMOUTH MEETING, PA [June 17, 2024] — The National Comprehensive Cancer Network® (NCCN®) today announced new recognitions for the award-winning library of NCCN Guidelines ...
Prince William Is All Smiles as Dad King Charles Skips 2nd Day of the Royal Ascot
US Weekly· 4 days agoPrince William made a royal appearance on day two of the Royal Ascot without his dad, King Charles...
FDA Expands Orphan Drug Designation for SurVaxM, I | Newswise
Newswise· 2 days agoBUFFALO, N.Y. — The U.S. Food and Drug Administration (FDA) has expanded orphan drug designation for SurVaxM, a brain cancer immunotherapy born in the labs of Roswell Park ...
Lantheus (LNTH) Gains 33.3% YTD: What's Driving the Stock?
Zacks· 5 days agoFree Report) witnessed strong momentum in the year-to-date period. Shares of the company have rallied 33.3% compared with 3.1% growth of the industry. With healthy fundamentals and strong growth ...
AstraZeneca's (AZN) Truqap Misses Endpoints in TNBC Study
Zacks via Yahoo Finance· 5 days agoAstraZeneca's (AZN) phase III CAPItello-290 study evaluating Truqap plus chemotherapy in patients...
AstraZeneca's Advanced Breast Cancer Drug Fails to Meet Primary Goals
Morningstar· 5 days agoAstraZeneca said a late-stage study showed that its therapy for advanced or metastatic triple-negative breast cancer didn't meet its primary goals. The British-Swedish pharma ...
Lilly and subsidiary Point Biopharma accused of patent infringement of cancer drugs - Indianapolis...
Indianapolis Business Journal· 6 days agoEli Lilly and Co. and a biopharma company it bought last year are accused of infringing on the...
Ads
related to: Prostate Cancer Treatment